e-learning
resources
London 2016
Sunday, 04.09.2016
Sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease
Katarzyna Furrer (Basel, Switzerland), Katarzyna Furrer Wacker, Christian Nebiker, Lilian Junker, Simona Lazdinyte, Spasenija Savic, Katrin Hostettler, Desiree Schumann, Joerg Halter, Michael Tamm, Didier Lardinois
Source:
International Congress 2016 – Sarcoidosis
Session:
Sarcoidosis
Session type:
Thematic Poster
Number:
835
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katarzyna Furrer (Basel, Switzerland), Katarzyna Furrer Wacker, Christian Nebiker, Lilian Junker, Simona Lazdinyte, Spasenija Savic, Katrin Hostettler, Desiree Schumann, Joerg Halter, Michael Tamm, Didier Lardinois. Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease. Eur Respir J 2016; 48: Suppl. 60, 835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Complications and mortality of tranbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease
Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Year: 2015
Surgical lung biopsies for diagnosis of interstitial lung disease
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
Source: Eur Respir J, 53 (2) 1801164; 10.1183/13993003.01164-2018
Year: 2019
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Does surgical lung biopsy change the diagnosis and treatment in interstitial lung diseases?
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Lung biopsy in the diagnostics of interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 561s
Year: 2007
Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Retrospective analysis of patients with interstitial lung disease on lung-transplantation waiting-list
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept